Upstart Q3 Preview: Shorts Trim But the Book Stays Heavy
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Upstart Holdings heads into its Q3 print on November 3 with one of the most contested positioning pictures in consumer finance: a short book that remains near multi-year highs is being trimmed at the margin, the stock just shed 7% in a single session, and options traders are leaning more bullish than they have been in months.
The short interest picture has shifted in direction without shifting in magnitude. At 28.2% of the free float, roughly 27.4 million shares are still on loan, a figure that FINRA's fortnightly official count corroborates at 26.9 million as of mid-October, with a days-to-cover ratio of 6.4. But shorts have been pulling back: the position fell nearly 5.6% over the past week, off a peak above 29 million shares in early October. The ORTEX short score of 75.4 places Upstart in the 3rd percentile of its universe, an extreme reading that has been broadly stable for the past two weeks rather than escalating. Availability in the lending pool has tightened to 45.5%, down 22% on the week, pointing to fewer shares left for new short positions to be built. The cost to borrow tells a calmer story, at 0.72% it has fallen 16% over the past month, so the borrow itself is not under stress even as room narrows.
Options positioning is the clearest divergence from that bearish framing. The put/call ratio at 0.53 is more than a full standard deviation below its 20-day average of 0.55, close to the 52-week low of 0.43. That tilt toward calls has been building steadily through October, in contrast to a PCR closer to 0.62 in late September. The stock itself fell 7.3% on Friday to $23.02, down 3.2% on the week, meaning call buyers are leaning into weakness rather than chasing strength.
The analyst community is divided, with the distance between targets reflecting genuinely different views of the model. Goldman Sachs cut its target from $39 to $28 in mid-October, keeping a Neutral rating, a signal that even a non-bear is moving the goalposts lower. Bulls, anchored at BTIG ($43) and Piper Sandler ($51), point to origination momentum running at 50% year over year and an expanding product set across personal, auto and other lending categories. Bears focus on the funding supply side: rising redemption requests at private credit funds, higher loan loss rates and CFPB regulatory risk could all compress transaction volumes and pressure fair-value marks on loans held on the balance sheet. The mean analyst target of $37.94 implies significant upside to current levels, but the stock has been below $30 for most of recent months, and that gap reflects the degree of uncertainty rather than a consensus call on recovery.
One piece of attention data adds colour without directional implication. Wikipedia page views for Upstart are running at a z-score of 2.1 against the stock's own 90-day history as of late October, a retail attention reading that is elevated relative to norm. That dataset has not been measured to lead the company's reported figures, so it is background context rather than a signal on the print.
The earnings report will test whether Upstart's origination volumes and take rates held up through Q3 in a funding environment that the bears argue is becoming more fragile.
Stocks in this article
See the live data behind this article on ORTEX.
Open UPST on ORTEX →How this article was generated
- Generated
- 2 Nov 2026, 04:42
- Data as of
- 2 Nov 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.